Anybody heard anything NEW about this subject since the BBC documentary in
2000?
PEPTIDE ANTIBIOTICS
BBC film producer Jill Fullerton-Smith, while taping a documentary about
crocodiles, made a startling observation: Australian salt-water crocodiles
fight constantly, inflict horrible wounds on each other, but never get
infected. The experts had no explanation. Analyzing a blood sample, Dr. Gill
Diamond of New Jersey Medical School, found a peptide that ``blew away
bacteria'' without damaging normal cells. The peptide is called crocodillin
(Sunday Times 3/17/00).
Will this be developed for possible human use? About 10 years of
bureaucratic delay and a cost of some $800 million stand in the way.
Readily synthesized peptides, modeled on sequences found in honey bees and
silk moths, were discovered by Dr. Bruce Merrifield and coworkers to be very
promising as antibiotics. Because his peptides are made with the d-isomer of
amino acids, they resist degradation by ordinary enzymes. However, no
commercial interest capable of affording the FDA hurdle-which was only $100
million at the time- could be found. The discovery languishes while multiply
drug-resistant bacteria proliferate. (Access to Energy, July 1996, available
in the 25-year CD-ROM Archive).
http://www.oism.org/ddp/ddpnews/ddpmar02.htm
Anybody heard anything NEW about this subject since the BBC documentary in
2000?
See:
http://www.chemheritage.org/EducationalServices/pharm/antibiot/readings/croc
.htm
http://www.bbc.co.uk/info/news/news226.htm
http://www.healthwatch-uk.org/nlett51.html
lynx - 10 May 2005 04:13 GMT
> Anybody heard anything NEW about this subject since the BBC documentary in
> 2000?
[quoted text clipped - 30 lines]
> Anybody heard anything NEW about this subject since the BBC documentary in
> 2000?
There have been a number of small companies which worked on the small animal
peptides and also synthetic ones for many years, starting in the 80's. One
notable one was Magainin - which has since changed its name to Genaera. In
any case, although there were several clinical candidates for use of these
peptides as topical agents, none has so far reached the clinic - as the
clinical trials did not show actual benefit (over vehicle alone). As far as
I know, none of the small antibacterial peptides has shown systemic
efficacy - probably due to poor pharmacokinetics [or degradation]. A
relatively recent article
http://www.news-medical.net/?id=214 mentions synthetic analogs of magainins
[developed at U Penn] which may have improved characteristics over the
naturally occurring ones. It is easy to find compounds that can kill
bacteria, even bacteria resistant to most antibacterial agents - but it is
not easy to find safe and effective compounds that are amenable to human
use.
--
lynx